Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al
- PMID: 31211601
- DOI: 10.1200/JCO.19.00932
Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al
Comment on
-
Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.J Clin Oncol. 2019 Mar 10;37(8):636-646. doi: 10.1200/JCO.18.00307. Epub 2019 Jan 24. J Clin Oncol. 2019. PMID: 30676859
-
Tamoxifen Pharmacogenetics and Metabolism: The Same Is Not the Same.J Clin Oncol. 2019 Aug 1;37(22):1981-1982. doi: 10.1200/JCO.19.00507. Epub 2019 Jun 18. J Clin Oncol. 2019. PMID: 31211600 No abstract available.
-
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM.J Clin Oncol. 2019 Aug 1;37(22):1982-1983. doi: 10.1200/JCO.19.00504. Epub 2019 Jun 18. J Clin Oncol. 2019. PMID: 31211604 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
